Ting Guo#; Xiao-Huan Tang#; Xiang-Yu Gao; Yuan Zhou; Bo Jin; Zi-Qian Deng; Ying Hu; Xiao- Fang Xing*; Zi-Yu Li*; Jia-Fu Ji*,Molecular Cancer,2022 Dec 12;21(1):216.

Ziqian Deng1#, Ting Guo1#, Jiwang Bi1, Gangjian Wang1, Ying Hu2, Hong Du1, Yuan Zhou3*, Shuqin Jia4*,Xiaofang Xing1* and Jiafu Ji1,5* profiling of patient-derived tumor xenografts suggests novel extracellular matrix-related signatures for gastric cancer prognosis prediction,Journal of Translational Medicine,2023 Sep 19;21(1):638

Xiao-Huan Tang#, Ting Guo#, Xiang-Yu Gao#, Xiao-Long Wu, Xiao-Fang Xing, Jia-Fu Ji, Zi-Yu Li. Exosome-derived noncoding RNAs in gastric cancer: functions and clinical applications.,Molecular Cancer,2021 Jul 30;20(1):99

Xueying Wang# ,Hui Hui#,Jing Han# ,Ting Guo#,Yiding Wang #,Lin Meng,Cong Chen ,Jie He,Xiaoyong Guo,Fuyu Zhong,Hong Du,Jie Tian,Xiaofang Xing,Yang Du ,Jiafu Ji A CLDN18.2-Targeted Nanoplatform Manipulates Magnetic Hyperthermia Spatiotemporally for Synergistic Immunotherapy in Gastric Cancer,Adv Sci (Weinh),Online ahead of print.

Ting Guo#, Yan-Hua Bai#, Shu-Qin Jia*, Xiao-Fang Xing*, Jia-Fu Ji*. Insulin gene enhancer protein 1 mediates glycolysis and tumorigenesis of gastric cancer through regulating glucose transporter 4. . 2021;41:258–272. IF: 10.392,Cancer Communications,2021;41:258–272

Yiding Wang#, Ting Guo#, Xiaofang Xing#, Xijuan Liu, Xuejun Gan, Yingai Li, Yan Liu, Fei Shan, Zhouqiao Wu, Jiafu Ji, Ziyu LiThe accumulation of myeloid-derived suppressor cells participates in abdominal infection-induced tumor progression through the PD-L1/PD-1 axis,Mol Oncol,Online ahead of print

Xiaohuan Tang#, Ting Guo#, Xiaolong Wu, Xuejun Gan, Yiding Wang, Fangzhou Jia , Yan Zhang, Xiaofang Xing* Xiangyu Gao* and Ziyu Li* Clinical Significance and Immune Infiltration Analyses of the Cuproptosis-Related Human Copper Proteome in Gastric Cancer.2022, 12, 1459. doi.org/10.3390/biom12101459,Biomolecules,

Yanhua Bai#, Ting Guo#,Dongfeng Niu#,Yanli Zhu, Wenhao Ren,?Qian Yao, Xiaozheng Huang, Qin Feng, Tianxiao Wang, Xiuli Ma, Xinqiang Ji. Clinical significance and interrelations of PD?L1 expression, Ki67 index, and molecular alterations in sporadic medullary thyroid carcinoma from a Chinese population,Virchows Archiv,,2022 Aug 3. doi: 10.1007/s00428-022-03390-9

Tao Li#, Ting Guo#, Houqin Liu, Hongtao Jiang*, Yi Wang*. Platelet?derived growth factor?BB mediates pancreatic cancer malignancy via regulation of the Hippo/Yes?associated protein signaling pathway. . IF: 3.906,Oncol Rep.,2021 Jan;45(1):83-94

Xiaoxia Jia#, Ting Guo#, Zhemin Li#,Xiaofang Xing*, Shuqin Jia*, Jiafu Ji. Clinicopathological and Immunomicroenvironment Characteristics of Epstein-Barr Virus-Associated Gastric Cancer in a Chinese Population. IF: 6.244,Front Oncol.,2021 Jan 8;10:586752.

Xiaohuan Tang 1#, Xiaolong Wu 1#, Ting Guo 1#, Fangzhou Jia 2, Ying Hu 2, Xiaofang Xing 1, Xiangyu Gao 1, Ziyu Li 1Focal Adhesion-Related Signatures Predict the Treatment Efficacy of Chemotherapy and Prognosis in Patients with Gastric Cancer.,Front Oncol.,2022 May 4;12:808817

2024年中华医学科学技术奖, 一等奖, 第5完成人, 中华医学会, 2025.1

北京市海淀区卫生健康委员会首届”海创杯“卫生健康科技创新大赛医疗器械与智能制造组三等奖, 三等奖, 第1完成人, 北京市海淀区卫生健康委员会, 2024.12

北京医学会2024年第四届首都医学创新与转化项目展示与科技评价活动三等奖, 三等奖, 第1完成人, 北京医学会, 2024.11

首届“技创杯”医疗器械技术创新与应用技能大赛一等奖, 一等奖, 第1完成人, 中国技术市场协会, 2024.10

血浆外泌体生物标志物在胃癌新辅助化疗敏感人群筛查或疗效预测中的应用, 一等奖, 第1完成人, 中国医学装备协会转化医学分会, 2024.1

血浆外泌体生物标志物在胃癌新辅助化疗敏感人群筛查或疗效预测中的应用, 发明专利, 第4完成人, 北京肿瘤医院, 中国, 2022.6

外泌体SRSF6通过选择性剪接PKM介导糖酵解重塑促进胃癌化疗耐药的机制研究, 课题负责人, 2025.1.1～2028.12.31, 国家自然科学基金面上项目

基于胃癌新辅助化疗临床队列的液体活检多模态疗效预测模型的构建及验证, 课题负责人, 2024.10.1～2026.9.30, 北京市自然科学基金

基于胃癌新辅助疗效的液态活检多组学预测早筛模型, 课题负责人, 2025.1.1～2025.12.31, 北京大学肿瘤医院科创项目转化方向

非编码RNA LINC01089抑制胃癌转移的分子机制研究, 课题负责人, 2020.1.1～2023.12.31, 国家自然基金面上项目

基于胃癌新辅助化疗的外泌体蛋白组学疗效预测模型的构建及验证, 课题负责人, 2024.1.1～2024.12.31, 北京大学肿瘤医院科创项目

基于外泌体RNA及胃癌新辅助化疗疗效预测模型及相关机制, 课题负责人, 2022.10.1～2023.12.31, 重点实验室开放课题联合基金

基于外泌体 RNA 的胃癌新辅助化疗疗效预测模型的构建及关键治疗靶点的机制探索, 课题负责人, 2023.1.1～2023.12.31, 北京大学医学青年科技创新“扬帆计划”医-X 项目

非编码RNA LIMT 作为ceRNA抑制胃癌发生转移的分子机制研究, 课题负责人, 2020.12.1～2021.12.31, 院内基金